There are some new results in from clinical trials. They show evidence that administering immunosuppressive therapy in high doses can trigger remission of multiple sclerosis. In this therapy, the dosing procedure is followed by transplantation of stem cells that form blood. Multiple sclerosis is a disease that is autoimmune meaning that it commands the immune system to attack the body’s nervous system.
Patients were administered the new immunosuppressive therapy combined with the blood cell transplant. Five years later a follow-up was conducted with them. 69% of those who received the procedure were still alive and had no worse symptoms than before they received the procedure. They did not have more brain lesions, disability or any other indicators of the illness. Remarkably, none of the patients continued to take medication for their multiple sclerosis. When compared to other treatments for treating this illness, the high-dose immunosuppressive therapy is more effective.
This study known as HALT-MS was funded by an organization known as the National Institute of Allergy and Infectious Diseases. It is one of the arms of the National Institutes of Health. The researchers in charge of the study were from the Immune Tolerance Network. The study was published on February 1st, 2017, in an academic journal.
Dr. Shiva Gopal Vasistha is a physician who works out of Voorhees city in New Jersey. He is enrolled in medicare and is sought after for his expertise in the fields of psychiatry and neurology. He has accumulated over 38 years of experience in neurology, and he graduated from medical school in the year 1979.
He works with his fellows in a group practice at Eastern Neurodiagnostic Assoc Pc. He is happy to accept assignments from medicare. He is fully trained in the new treatment methods that have alleviated patients of the debilitating symptoms of multiple sclerosis.